Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 83.47% |
| 2 | Technology | 3.02% |
| 3 | Healthcare | 2.92% |
| 4 | Consumer Discretionary | 2.17% |
| 5 | Financials | 2.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
10101
CALL
iShares MSCI Chile ETF
ECH
$962M
| $196K | ﹤0.01% |
7,200
-6,300
| -47% | -$164K |
2017 Q1
30 quarters
|
|
10102
PUT
Invesco S&P 500 High Beta ETF
SPHB
$973M
| $196K | ﹤0.01% |
2,200
-800
| -27% | -$68K |
2022 Q3
8 quarters
|
|
10103
PUT
Arlo Technologies
ARLO
$1.33B
| $196K | ﹤0.01% |
16,200
-7,700
| -32% | -$102K |
2022 Q4
7 quarters
|
|
|
MSTU
10104
T-Rex 2X Long MSTR Daily Target ETF
MSTU
$801M
| $196K | ﹤0.01% |
+489
| New | +$168K |
2024 Q3
0 quarters
|
|
10105
PUT
Fidus Investment
FDUS
$758M
| $196K | ﹤0.01% |
10,000
-300
| -3% | -$5.9K |
2022 Q4
7 quarters
|
|
10106
CALL
YieldMax Ultra Option Income Strategy ETF
ULTY
$709M
| $196K | ﹤0.01% |
1,850
+1,710
| +1,221% | +$201K |
2024 Q2
1 quarter
|
|
10107
PUT
Kirby Corp
KEX
$7.19B
| $196K | ﹤0.01% |
1,600
+500
| +45% | +$59.6K |
2023 Q2
5 quarters
|
|
|
PVLA
10108
Palvella Therapeutics
PVLA
$2B
| $196K | ﹤0.01% |
+11,686
| New | +$171K |
2024 Q3
0 quarters
|
|
10109
RGC Resources
RGCO
$232M
| $196K | ﹤0.01% |
+8,662
| New | +$181K |
2024 Q3
0 quarters
|
|
10110
CALL
Wrap Technologies
WRAP
$87.7M
| $195K | ﹤0.01% |
130,300
-63,500
| -33% | -$103K |
2019 Q4
19 quarters
|
|
10111
PUT
iShares MSCI Sweden ETF
EWD
$962M
| $195K | ﹤0.01% |
4,500
+3,500
| +350% | +$143K |
2022 Q4
7 quarters
|
|
10112
CALL
Universal Technical Institute
UTI
$1.14B
| $195K | ﹤0.01% |
12,000
-5,700
| -32% | -$97.7K |
2023 Q3
4 quarters
|
|
10113
PUT
Invesco DB US Dollar Index Bearish Fund
UDN
$102M
| $195K | ﹤0.01% |
10,300
+10,000
| +3,333% | +$185K |
2022 Q4
7 quarters
|
|
10114
Tradr 2X Long Innovation ETF
TARK
$17.5M
| $195K | ﹤0.01% |
6,000
-13,236
| -69% | -$397K |
2023 Q1
6 quarters
|
|
10115
CALL
ProShares Short Russell2000
RWM
$155M
| $195K | ﹤0.01% |
+10,300
| New | +$204K |
2024 Q3
0 quarters
|
|
|
DRD
10116
CALL
DRDGold
DRD
$2.16B
| $195K | ﹤0.01% |
20,200
+7,100
| +54% | +$65.6K |
2021 Q3
12 quarters
|
|
|
CSGS
10117
CALL
DELISTED
CSG Systems International
CSGS
| $195K | ﹤0.01% |
4,000
-1,800
| -31% | -$82K |
2022 Q4
7 quarters
|
|
10118
Scorpio Tankers
STNG
$4.26B
| $194K | ﹤0.01% |
2,727
-335,344
| -99% | -$24.5M |
2013 Q2
45 quarters
|
|
10119
C4 Therapeutics
CCCC
$389M
| $194K | ﹤0.01% |
34,097
-339,560
| -91% | -$2.04M |
2020 Q4
15 quarters
|
|
10120
BlackRock MuniYield Michigan Quality Fund
MIY
$332M
| $194K | ﹤0.01% |
+16,178
| New | +$189K |
2024 Q3
0 quarters
|
|
|
ENV
10121
CALL
DELISTED
ENVESTNET, INC.
ENV
| $194K | ﹤0.01% |
3,100
-3,300
| -52% | -$206K |
2017 Q1
30 quarters
|
|
10122
CALL
StealthGas
GASS
$341M
| $194K | ﹤0.01% |
28,500
+10,500
| +58% | +$68.1K |
2021 Q1
14 quarters
|
|
10123
CALL
Prime Medicine
PRME
$724M
| $194K | ﹤0.01% |
50,100
-23,900
| -32% | -$111K |
2023 Q3
4 quarters
|
|
10124
Coda Octopus Group
CODA
$116M
| $194K | ﹤0.01% |
26,720
+4,489
| +20% | +$31.3K |
2023 Q4
3 quarters
|
|
10125
PUT
Lexicon Pharmaceuticals
LXRX
$748M
| $193K | ﹤0.01% |
123,200
+26,200
| +27% | +$46.7K |
2022 Q4
7 quarters
|
|
Similar funds
Citadel Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, Citadel Advisors held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citadel Advisors's Q3 2024 filing shows 1,612 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 82% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Citadel Advisors added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Citadel Advisors's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Citadel Advisors fully exited Domino's in Q3 2024, selling an estimated $186M.
- Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Citadel Advisors opened 1,612 new positions and closed 1,610 in Q3 2024.
- Citadel Advisors's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.